Purification, Characterization and Inhibition of Alanine Racemase from a Pathogenic Strain of Streptococcus iniae by MUHAMMAD, MURTALA et al.
Polish Journal of Microbiology
2019, Vol. 68, No 3, 331–341
https://doi.org/10.33073/pjm-2019-036
ORIGINAL PAPER
* Corresponding author: B. Zhao and D. Liu, College of Life Science, Hebei Normal University, Shijiazhuang, China;
 e-mail: Baohua519@126.com, pqw1234@163.com
© 2019 Murtala Muhammad et al.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License (https://creativecommons.
org/licenses/by-nc-nd/4.0/).
Introduction
Streptococcus iniae is a Gram-positive and most 
commonly reported Streptococcal pathogen of fish 
responsible for high economic loses of aquaculture 
industries around the world. The zoonotic bacteria was 
also reported to cause bacteremia, cellulitis, meningitis, 
and osteomyelitis in human (Guo et al. 2018; Tavares 
et al. 2018). Vaccines and antibiotics were currently 
employed for minimizing the impact of the disease. 
However, recent studies revealed that the bacteria has 
so far developed resistance against many potential anti-
biotics (Tavares et al. 2018). As such, additional efforts 
for developing more effective vaccines and antibiotics 
are necessary steps for circumventing the threat of its 
infection (Saavedra et al. 2004). 
Alanine racemase (Alr; E.C. 5.1.1.1) is an enzyme 
that catalyzes the interconversion of L-alanine and 
D-alanine using a pyridoxal 5-phosphate (PLP) as 
a cofactor (Tassoni et al. 2017). It provides D-alanine 
for the synthesis of peptidoglycan of the bacterial cell 
wall, D-alanine is directly involved in cross-linking 
of adjacent peptidoglycan strands and also present in 
lipoteichoic acids of Gram-positive bacteria (Liu et al. 
2018; Ray et al. 2018). There are two isoforms (non-
homologous) of the alanine racemase genes (alr and 
dadX). The alr gene, which is constitutively expressed 
encodes for an essential enzyme for cell wall synthesis. 
While the expression of dadX is induced in the pres-
ence of high concentrations of L- or D-alanine. DadX is 
required for L-alanine catabolism, forming a substrate 
for D-alanine dehydrogenase (dadA) (Duque et al. 
2017). The bacterial cell wall is indispensable for the 
survival and viability of bacteria (Liu et al. 2019) and 
has always been an attractive target for many antibiot-
ics and antimicrobial agents (Anthony et al. 2011). Ala-
nine racemase is ubiquitous among bacteria and rare 
in eukaryotes but absent in humans (Kawakami et al. 
2018); hence, it emerges as an attractive and potential 
therapeutic target for the antimicrobial drugs develop-
ment (Wang et al. 2017).
Numerous inhibitors were identified as able to affect 
the activity of alanine racemase (Kim et al. 2003a; Kim 
et al. 2003b). Many of these inhibitors were structural 
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A b s t r a c t
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analogs of alanine; they interact with the enzyme-
bound PLP, covalently bound to some eukaryotic 
PLP-dependent enzymes and lead to cellular toxicity 
(Toney 2005). PLP-related off-target effects could be 
overcome by using enzyme inhibitors that are not sub-
strate analogs. Structure-based approach and molecular 
modeling have been employed to discover novel alanine 
racemase inhibitors, which are devoid of affinity for the 
PLP and hence off-target effects (Lee et al. 2013; Azam 
and Jayaram 2018).
In this study, we identified and purified the ala-
nine racemase from S. iniae HNM-1 strain that was 
previously isolated from an infected Chinese sturgeon 
(A. sinensis). We have characterized its enzymatic prop-
erties, substrate specificity, and kinetic parameters. 
We have also explored the potentiality of the enzyme 
as an attractive antimicrobial target against S. iniae. We 
determined the 50% inhibition concentrations (IC50) of 
two alanine racemase inhibitors (homogentisic acid and 
hydroquinone) and their antimicrobial susceptibility 
against six opportunistic pathogens including S. iniae, 
in quest of providing the possible solutions against anti-
biotics resistance and bacterial infections.
Experimental
Materials and Methods
Strains, plasmids, and growth conditions. The 
characteristics of bacterial strains and plasmids used 
in this context were summarized in Table  I. S. iniae 
HNM-1 was cultured at 35°C in the Tryptone soy yeast 
extract (TSYE) medium. Escherichia coli DH5α, E. coli 
BL21 strains, Salmonella Typhimurium, Staphylococcus 
aureus, Acinetobacter baumannii, and Pseudomonas 
aeruginosa were cultured in Luria Bertani (LB) medium 
at 37°C or 35°C. 100 g/ml final concentration of ampi-
cillin (Amp) was used in this study.
Cloning of alanine racemase gene. Primers were 
designed based on the alr gene sequence of S. iniae 
89353 strain (NCBI accession number CP017952.1). 
The genomic DNA of S. iniae HNM-1was extracted 
and amplified using the following primers, Alr-F-(5’-
GCACCATGGATGATTTCAAGTTTG-3’) and Alr-R- 
(5’-TCACTCGAGATCCCGATAAAGC-3’), with NcoI 
and XhoI restriction sites, underlined respectively. PCR 
product was cloned in pMD19-T cloning vector to con-
struct pMD-alr and transformed to E. coli DH5α. The 
alr gene was digested with restriction endonucleases 
and cloned into expression vector pET-22b (+), form-
ing recombinant plasmid pET22b-alr. The deduced 
amino acid sequence of the ORF was analyzed by the 
Blast software. Multiple amino acid sequence alignment 
and phylogenetic relationships among alanine racemase 
of S. iniae and other bacteria were constructed with 
Clustal Omega.
The evolutionary distances of the phylogenic tree 
were computed using the p-distance method and are 
reported in the units of the number of amino acid dif-
ferences per site. The bootstrap consensus tree inferred 
from 500 replicates was used to represent the evolution-
ary history (Felsenstein 1985). The analysis involved 
10 amino acid sequences from S. iniae (NCBI Genbank 
accession number: APD32491.1), P. aeruginosa PAO1 
(NCBI Genbank accession number: AF165882), Strep­
tococcus agalactiae (NCBI Genbank accession num-
ber: WP_037624882), Enterococcus feacalis (NCBI 
Genbank accession number: AFO43552.1), Strepto­
coccus pyogenes (NCBI Genbank accession number: 
MGAS10750), Staphylococcus aureus (NCBI Gen-
bank accession number: CAG41139.1), Corynebacte­
rium glutamicum (NCBI Genbank accession number: 
AAL77207.1), Aeromonas hydrophyla (NCBI Gen-
bank accession number: ABK36160.1), Streptococ­
cus pneumoniae (NCBI Genbank accession number: 
AAL00344.1), and E. coli (NCBI Genbank accession 
number: YP_002407858).
Strains
Streptococcus iniae HNM-1 Isolated from infected A. sinensis This study
Escherichia coli DH5α Used for cloning and propagation of plasmids Novagen
Escherichia coli BL21(DE3) Used for protein expression Invitrogen
Salmonella typhimurium  This study
Staphylococcus aureus  This study
Acinetobacter baumannii  This study
Pseudomonas aeruginosa  This study
Plasmids
pMD19-T Carries ampR gene; used for cloning PCR product with A at 3’ ends Takara
pET 22b (+) Carries ampR gene; used for expressing S. iniae Alanine racemase Novagen
Table I
Strains and plasmids used in this study.
Strains/Plasmids Description Source
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Expression and purification of alanine racemase. 
E. coli BL21 (DE3) was transformed with expression 
vector pET22b-Alr for protein expression, a  single 
colony of the transformed E. coli was inoculated in 
100 ml LB medium at 35°C. Protein expression was 
induced when the OD600 reaches 0.6 by addition of 
IPTG at a  final concentration of 1 mM, and re-incu-
bated overnight at 16°C or at 35°C for 5 hours. Cells 
were collected and resuspended in 20 ml binding buffer 
(50 mM NaH2PO4, pH 8.0, 300 mM NaCl, and 10 mM 
imidazole), lysed on ice by sonication for 40 minutes, 
and centrifuged at 8000 g, 4°C for 10 minutes. The 
supernatant was collected and purified using Nickel 
ion affinity chromatography (Qiagen), according to 
the manufacturer’s protocol. The protein solution was 
dialyzed against phosphate buffered saline (PBS, pH 
7.4). Protein purity and concentration were determined 
by SDS-PAGE and BCA protein assay kit (Takara), 
respectively. Western blotting was conducted using 
a monoclonal antibody against the poly-Histidine tag 
attached to the Alr protein as described previously 
(Liu et al. 2015).
Enzyme assay. Alanine racemase racemization assay 
was conducted in two coupled enzyme reactions, using 
a  standard racemization mixture (Wang et al. 2017). 
The reaction was initiated by addition of the suitable 
concentration of SiAlr in the final reaction volume of 
200 µl, incubated at 35°C for 10 minutes, terminated 
by addition of 25 µl of 2 M HCl and neutralized with 
25 µl of 2 M sodium hydroxide. Then, the reaction mix-
ture was centrifuged at 14 000 rpm, 4°C for 10 min-
utes. The concentration of D-alanine was analyzed in 
the second reaction containing 200 mM Tris- HCl pH: 
8.0, 0.2 mg/ml 4-aminoantipyrine, 0.2 mg of N-ethyl-
N-(2-hydroxy-3-sulfopropyl)-3-methyl aniline, 1 unit 
of HRP, and 0.1 unit of D-Amino acid oxidase. The 
absor bance was measured using a microplate reader at 
550 nm after 20 min incubation at 37°C.
Effect of temperature and pH on enzyme activ-
ity and stability. The influence of temperature was 
determined according to a standard enzyme assay by 
measuring the initial rate of reaction at various tem-
peratures (10°C to 50°C), while the effect of pH was 
determined by measuring the initial rate of reaction in 
Britton-Robinson buffer (pH 2.0 to 12.0) at the opti-
mum temperature. The relative residual activity was cal-
culated with the highest activity as 100%. The thermal 
stability of the enzyme was examined by preincubation 
in the reaction buffer without substrate at temperatures 
of 30°C, 35°C, and 40°C for 2 h followed by addition of 
L-alanine as a substrate for determination of the rela-
tive residual enzyme activity. The pH stability of the 
enzyme was examined by incubation of the enzyme in 
the reaction buffers without substrate at pH ranging 
from 8.5 to 11.0 on ice for 2 hours, and subsequently, 
L-alanine was added and the relative residual enzyme 
activity was measured.
Substrate specificity of alanine racemase. The sub-
strate specificity of SiAlr was determined according 
to the standard racemization reaction mixture using 
18 kinds of L-amino acids as the substrates and incu-
bated at the optimum temperature for 10 minutes.
Effect of metal ions, reducing agents and PLP on 
the enzyme activity. The influence of some metal ions 
and chemical compounds on the activity of SiAlr were 
determined by incubating the enzyme with the chemi-
cal compounds in the reaction mixture for 30 min, 
afterward, the substrate was added and the relative 
residual activity was determined according to the 
standard protocol (Liu et al. 2015).
SiAlr and different concentrations of hydroxy-
lamine (0.1, 1, and 10 mM) were added to the reac-
tion mixture without the substrate, dialyzed in phos-
phate buffered saline for 40 min, and its activity was 
determined without the addition of PLP. The effect of 
Dithiothreitol (DTT) on the activity of SiAlr was also 
determined by incubating the enzyme in different con-
centrations of DTT (1 and 3 mM) for 30 minutes and 
the relative activity was measured. To confirm SiAlr is 
a PLP-dependent enzyme, the purified Alr was treated 
with 10 mM hydroxylamine and dialyzed to obtain the 
apoenzyme. The apoenzyme was incubated in different 
concentrations of PLP (0.01, 0.04, and 0.06 mM) and its 
relative activity was measured. 
Kinetic parameters. The alanine racemase activ-
ity was determined by measuring the amount of both 
enantiomers of alanine by high-performance liquid 
chromatography (HPLC) using a fluorescence detec-
tor according to the method described earlier (Hashi-
moto et al. 1992). The reaction mixture comprised 
of 10 µm PLP, 200 mM carbonate buffer pH 9.5, and 
various concentrations of either L or D forms of ala-
nine. The enzymatic reaction was initiated by adding 
the purified SiAlr, followed by 10 min of incubation 
at 35°C. The reaction was terminated by the addition 
of 40 µl of 2 M HCl on ice for 2 min, neutralized with 
40 µl of 2 M NaOH, and centrifuged at 10 000 g, 4°C 
for 5 min. A 40 µl aliquot of the reaction was derivat-
ized by addition of 280 µl of 0.4 M boric acid pH 9.0, 
0.1% N-tert-butyloxycarbonyl-L-cysteine (Sigma), and 
0.1% O-phthaldialdehyde. One unit of the enzyme was 
defined as the amount of the enzyme that catalyzed 
the formation of 1 µmol of L- or D-alanine from either 
enantiomer per minute. Graph Pad Prism 6.0 was used 
for results analysis.
Enzyme IC50 determination. Inhibitory effects of 
homogentisic acid and hydroquinone on the activity 
of alanine racemase were determined as described 
previously (Wang et al. 2017). Fivefold dilution series 
(in DMSO) was prepared for the compounds, and the 
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solutions were added to the wells of a 96-well plate to 
yield the final inhibitory concentrations. Each concen- 
tration was tested in triplicate. The substrate was added 
after 30 min of incubation, and the fluorescence intensity 
was measured after the reaction. The negative control 
was prepared without adding chemicals to the control 
wells and the D-cycloserine (DCS) was used as a positive 
control. Percentage inhibition at each inhibitor concen-
tration was calculated with respect to the negative con-
trol. Graph Pad Prism 6.0 was used for the calculation 
of the concentration that causes 50% inhibition (IC50).
Antimicrobial susceptibility tests. Minimum inhi- 
 bition concentrations (MIC) of hydroquinone and 
homogentisic acid against both Gram-positive and 
Gram-negative bacteria were determined by microdi-
lution assay according to the guidelines of the Clinical 
and Laboratory Standards Institute, document M31-A3 
(CLSI 2008), as described previously (Dal Pozzo et al. 
2011). An overnight culture was subcultured to OD600 of 
0.3, diluted tenfold, five times. Aliquots were spread on 
agar plates in triplicate to determine the number of col-
ony-forming units (CFU)/ml. Compounds were diluted 
in DMSO at concentrations of 200, 100, 80, 40, 20, or 
10 μg/ml. DMSO solvent was used as a negative control 
of growth inhibition and DMSO alone was used as the 
blank control. All tests were performed in triplicate. The 
inoculums were prepared in LB medium (1 × 108 CFU/
ml) and incubated at 30°C for 20 h. Subsequently, 100 μl 
(1 × 105 CFU) of the inoculums and the inhibitors were 
added to each microplates wells and incubated at 30°C 
for 48 h. The MIC values were determined as the lowest 
concentration of the inhibitors at which no growth of 
the bacteria was observed after incubation.
Results
Identification of S. iniae alanine racemase gene. 
According to the genomic sequence of S. iniae, the 
bacteria have a single putative alanine racemase (alr) 
gene. The alr gene has an open reading frame of 1107 bp 
that encodes a 369 amino acids protein (SiAlr) with 
a molecular mass of 39.82 kDa. The nucleotide sequence 
of alr has been submitted to Genbank under accession 
number MK620909. 
The deduced amino acid sequence has 76%, 67%, 
63%, and 47% similarities with alanine racemase of 
Streptococcus pyogenes, Streptococcus agalactiae, Strepto­
coccus pneumoniae, and Enterococcus faecalis, respec-
tively. Phylogenetic analysis of alanine racemase from 
different bacteria revealed an evolutionary relation-
ship among them. The phylogenetic tree consists of 
two distinct clades. The enzyme is clustered with other 
Streptococci species, such as S. pyogenes, S. agalactiae, 
S. pneumoniae, and E. faecalis. These sequences, from 
Gram-positive bacteria, were classified into one group. 
The sequences from Gram-negative bacteria, such as 
Pseudomonas aeruginosa, Aeromonas hydrophila, and 
Corynebacterium  glutamicum were classified into 
another (Fig. 1). The evidence indicated that these ala-
nine racemases evolved independently from a common 
ancestor and formed two isolated genes.
Multiple sequence alignment of SiAlr with sequences 
of other 10 species Alr suggested that some regions are 
conserved in SiAlr, which includes PLP binding motif 
near the N-terminus (AVVKANAYGHG) and the two 
catalytic amino acid residues of the active center (Lys 40 
and Tyr 274). The eight residues making up the entry-
way to the active site (inner layer: Ala  174, Tyr  273, 
Tyr 282 and Tyr 366; middle layer: Asp 166, Arg 298, 
Arg 318 and Ile 364) (Fig. 2).
Expression and Purification of SiAlr. The SiAlr 
protein was expressed in E. coli (DE3) incubated over-
night at 16°C, and purified to homogeneity using 
Ni-agarose affinity chromatography. The protein has 
a relative molecular mass of 39.82 kDa as estimated by 
SDS-PAGE, which was similar to the calculated rela-
tive molecular mass. Western blotting analysis using 
the anti-poly-His antibody confirmed that 39.82 kDa 
protein is SiAlr (Fig. 3).
Characterization of the enzyme. The optimal tem-
perature of SiAlr was approximately 35°C. The enzyme 
was found to be very stable at the temperature of 30°C 
and 35°C, with more than 50% residual activity. The 
optimal pH of SiAlr was approximately 9.5 at 35°C. 
The enzyme was found to be very stable, with more 
than 50% residual activity after incubation for 2 hours 
at a pH range of 8.5 to 9.5 (Fig. 4). Thus demonstrating 
that SiAlr is a basophilic enzyme.
Fig. 1. Phylogenetic relationships of SiAlr and homologs alanine 
racemases from Pseudomonas aeruginosa PAO1, Corynebacte­
rium glutamicum ATCC 13032, Aeromonas hydrophyla ATCC 
7966, Staphylococcus aureus ABFQT, Enterococcus feacalis D32, 
Streptococcus pneumoniae MDRSPN001, Streptococcus agalactiae 
2603V/R, Streptococcus pyogenes MGAS10750 and Streptococcus 
dysgalactiae Kdys0611. The tree was constructed using Neighbor 
end-joining. Maximum likelihood tree based on complete coding 
sequences deposited in Genbank. The evolutionary distances were 
computed using the p-distance method and are reported in the 
units of the number of amino acid differences per site. 
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Various chemicals and metal ions were reported to 
inhibit the activity of alanine racemases. The results 
revealed that the enzyme activity was inhibited by most 
of the metal ions, but markedly inhibited by Ni2+, Co2+ 
Zn2+, and Fe2+ (Fig. 5). 
Effect of reducing agents on the activity of SiAlr. 
Many inhibitors of alanine racemase have been dis-
covered (Wang et al. 2017). The enzyme lost its activity 
after treatment with 1 or 10 mM hydroxylamine. Addi-
tion of 0.1 mM hydroxylamine reduced the activity of 
Fig. 2. Structure-based sequence alignment of alanine racemases sequences. The amino acid sequence of Alr from Streptococcus iniae 
was aligned with alanine racemases sequences of Streptococcus pyogenes MGAS10750, Streptococcus dysgalactiae Kdys0611, Streptococcus 
agalactiae 2603V/R, Streptococcus pneumoniae MDRSPN001, Enterococcus feacalis D32, Pseudomonas aeruginosa PAO1, Staphylococcus 
aureus ABFQT, Corynebacterium glutamicum ATCC 13032 and Aeromonas hydrophyla ATCC 7966. The red box enclosed the conserved 
PLP-binding sites; Lys40 (*), Tyr44 (#). The catalytic Tyr residue was indicated by (+). Strictly conserved residues were enclosed in the 
black boxes, while the hydrophobic patch (HP) in the yellow box. Residues of the active site entryway are marked with either I (inner 
layer) or M (middle layer). Highly conserved residues were indicated by the box and strictly conserved with (*).
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the enzyme by 80%. Treatment of SiAlr with 1 mM of 
DTT resulted in a 70% loss of activity and completely 
inhibition at the concentration of 3 mM (Table II).
We examined the role of PLP in the activity of SiAlr 
by resolving the enzyme to Apo-enzyme by hydroxy-
lamine treatment. The Apo-enzyme completely lost its 
activity after treatment with 10 mM hydroxylamine. 
Addition of 0.01, 0.04, and 0.06 mM of PLP make the 
enzyme regained up to 56%, 83 % and 96% of its activ-
ity, respectively. The result indicated that SiAlr is a PLP-
dependent enzyme that requires more than 0.01 mM 
PLP to maintain its activity (Table II). 
Substrate specificity. Alanine racemase is a highly 
conserved bacterial enzyme and known to be very spe-
cific to its substrate (Patrick et al. 2002). As shown in 
Fig. 6, the enzyme is highly specific to L-alanine and 
None  100 (0.7)
Hydroxylamine 0.1 21 (1.2)
 1 11 (0.8)
 10 9 (1.4)
DTT 1 27 (3.1)
 3 2 (0.8)
PLP 0.01 56 (2.4)
 0.04 83 (1.5)
 0.06 96 (2.7)
Table II
Effect of Hydroxylamine, DTT and PLP on SiAlr Activity.
The data were presented as mean (SD)
from three independent enzyme reactions
Chemical Concentration(mM)
Relative activity
(%)
Fig. 3. Purification of Streptococcus iniae alanine racemase.
The enzyme was purified using Nickel ion affinity chromatogra-
phy, analyzed by SDS-PAGE and western blotting. M: molecular 
weight standards; 1; 40 kDa SiAlr. 2: Western blotting analysis of 
the purified protein.
Fig. 4. Effect of pH and temperature on the activity of SiAlr.
(A) Optimal pH, (B) pH stability, (C) Optimal temperature, (D) Thermal stability.
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showed weak activity with L-phenylalanine (11%), 
L-Histidine (20%), and L-Asparagine (10%). This result 
indicates that SiAlr has strict substrate specificity. 
Kinetic parameters determination. Kinetic param-
eters of SiAlr were determined using HPLC. The sub-
strate affinity constant (Km) for L-alanine was 33.11 mM 
with a maximal velocity (Vmax) of 2426 units/mg, while 
the D-alanine Km value was 14.36 mM with a Vmax of 
963.6 units/mg. The Vmax of L-alanine was more than 
twice that of its enantiomer. These indicated that the 
enzyme has a higher binding affinity for L-alanine than 
for D-alanine, and the conversion of L- to D-alanine 
was more rapid than the reverse conversion. The equi-
librium constant (Keq (L/D)) was 1.09, which is consist-
ent with the reported theoretical equilibrium constant 
(Keq = 1) for alanine racemase (Liu et al. 2015).
IC50 determination. In our previous study, we found 
that homogentisic acid and hydroquinone are two ala-
nine racemase inhibitors with minimal cytotoxicity 
against mammalian cells and can be utilized as potential 
Fig. 6. The substrate specificity of SiAlr. The relative activity of SiAlr for various L-Amino acids
 was determined at optimum pH and temperature. The data were presented as mean ± SD from 3 independent enzyme assays.
Fig. 5. Effect of metals on SiAlr activity. The metal ions were at a concentration of 10 mM/L.
The data were presented as mean ± SD from 3 independent determinations.
Con
trol Cu
2+
Sr
2+
Ca
2+
Na
2+
Mn
2+
Mg
2+
Fe
2+
Ni
2+
Co
2+
Al
2+
Zn
2+
Metal ions (10 mmol/L)
Muhammad M. et al. 3338
agents of antibiotics (Wang et al. 2017). In this study, 
we investigated the inhibitory effects of homogentisic 
acid and hydroquinone on SiAlr. DMSO was used as 
the blank control and DCS, a known alanine racemase 
inhibitor, as the positive control. The results showed that 
the IC50 values of hydroquinone and homogentisic acid 
were 11.39 µM and 12.27 µM. The IC50 values of hydro-
quinone and homogentisic acid were 3 and 3.3  times 
higher than that of DCS, respectively (Fig. 7). 
Antimicrobial activity of alanine racemase inhibi-
tors. The MIC was assayed to determine the antimi-
crobial activity of two alanine racemase inhibitors 
against S. iniae HNM-1 and several pathogenic bac-
te ria (Table  III). The results showed that hydroqui-
none and homogentisic acid have broad-spectrum 
antibiotic activities against both Gram-positive and 
Gram-negative bacteria. Hydroquinone showed good 
antibiotic activity against S. iniae HNM-1 with MIC 
value of 25 µg/ml, however, it showed moderate anti-
biotic activity against other strains with MIC value 
of 130–210 µg/ml. Homogentisic acid demonstrated 
moderate antibiotic activity against the bacteria tested, 
with MIC value of 180–250 µg/ml. Interestingly, hydro-
quinone and homogentisic acid had no antibiotic activ-
ity against P. aeruginosa.
Discussion
Streptococcus iniae is one of the pathogenic Gram-
positive bacteria that causes morbidity and mortality 
of farmed and wild fish (Aruety et al. 2016). S. iniae 
HNM-1 strain was isolated from an infected Chinese 
sturgeon (A. Sinensis) after a  disease outbreak that 
caused high morbidity and mortality. The classification 
of S. iniae HNM-1 was confirmed by molecular analysis 
of 16s rRNA gene sequence. The sequence was depos-
ited at the NCBI Genbank database under accession 
number KY781829. The bacteria have a single putative 
alanine racemase (alr) gene. As reported earlier, most 
of the Gram-positive bacteria, including Lactobacil­
lus plantarum (Palumbo et al. 2004), Bacillus anthra­
cis (Couñago et al. 2009), Mycobacterium tuberculosis 
(Nakatani et al. 2017), and Mycobacterium smegmatis 
(Chacon et al. 2002), appear to possess only one alanine 
racemase gene.
The optimal pH and temperature of SiAlr were 9.5 
and 35°C, respectively, which were similar to alanine 
racemase from A. hydrophila (Liu et al. 2015) and Bacil­
lus pseudofirmus OF4 (Ju et al. 2009). Nearly all char-
acterized alanine racemases have optimal pH of more 
Streptococcus iniae HNM-1  25 (2.3) 200 (5.6)
Escherichia coli DH5α 130 (7.9) 210 (8.4)
Salmonella typhimurium 150 (8.7) 180 (11.4)
Staphylococcus aureus 210 (13.7) 250 (14.1)
Acinetobacter baumannii 180 (11.5) 210 (12.3)
Pseudomonas aeruginosa  0  0
Table III
The results of antimicrobial activity of homogentisic acid
and hydro quinone inhibitors against numerous isolates
of Gram-positive and Gram-negative bacteria.
a MIC, average values with standard deviations
Organism
aMIC (µg/ml)
Hydro-
quinone
Homogentisic
Acid
Fig. 7. IC50 of the Streptococcus iniae alanine racemase
inhi bitors.
A: IC50 of Hydroquinone was 11.39 µM; B: IC50 of homo gentisic acid 
was 12.27 µM; C: IC50 of D-cycloserine was 3.69 µM. The data shown 
are the means from three independent experiments.
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than 8.0 (Seow et al. 1998; Francois and Kappock 2007). 
SiAlr is a mesophilic enzyme, stable at a temperature 
from 0°C to 40°C. Thermal stability of an enzyme is cor-
related with the host bacteria physiology and environ-
ment, thermophilic bacteria Alr are more stable than 
that of mesophilic and psychrotroph bacteria (Soda and 
Tanizawa 1990; Yokoigawa et al. 1993). SiAlr was inhib-
ited by metal ions, such as Ni2+, Co2+, Zn2+, and Fe2+, 
which indicated that some divalent metal ions could 
influence the enzyme-substrate complex formation in 
such a way that favor decrease of enzyme activity. Simi-
larly, treatment of SiAlr with 1 mM of DTT resulted 
in a 70% loss of activity and the complete inhibition 
at the concentration of 3 mM. However, the activity 
of alanine racemase from Tolypocladium inflatum has 
increased in the presence of DTT (Di Salvo et al. 2013). 
DTT reduces cysteine side chains and causes a reduc-
tion of intermolecular disulfide bonds, which may 
affect the enzyme conformation and eventually enhance 
or inhibit its activity. SiAlr requires exogenous PLP for 
its activity in contrast to Alr from B. pseudofirmus OF4 
and Thalassiosira sp., which does not require exogenous 
PLP for optimal activity (Ju et al. 2009). The enzyme 
showed high substrate specificity to alanine, which is 
similar to most of the characterized alanine racemases 
(Kawakami et al. 2018). 
Many studies have focused on alanine racemase to 
develop antibacterial drugs for multiple bacterial spe-
cies (Scaletti et al. 2012; Shrestha et al. 2017). Although 
the MIC values of homogentisic acid and hydroqui-
none were higher than that of D-cycloserine, which 
is a cyclic analog of alanine and exerted its inhibitory 
effect through interaction with the enzyme-bound PLP 
cofactor (Batson et al. 2017), both homogentisic acid 
and hydroquinone are not structural analogs of Alr as 
such they are not interfering with other PLP dependent 
enzymes, but directly interact with the active sites of 
alanine racemase (Wang et al. 2017). According to the 
results of antimicrobial activity assay, the two inhibi-
tors are capable of inhibiting both Gram-positive and 
Gram-negative bacteria with various efficacies, except 
P. aeruginosa. The reason the two compounds showed 
no antimicrobial activity against P. aeruginosa may 
be because homogentisic acid is a normal product of 
P. aeruginosa and it also contained hydroquinone oxi-
dase that oxidized hydroquinone (Higashi 1958; Hunter 
and Newman 2010). 
Several alanine racemases have been identified and 
characterized form the Streptococcus species. Alanine 
racemase from Streptococcus faecalis NCIB 6459 with 
the molecular weight of 42 kDa was the first one that 
was purified and characterized (Badet and Walsh 1985). 
Strych et al. (2007) isolated and characterized the ala-
nine racemase gene from S. pneumoniae. They obtained 
preliminary crystals of S. pneumoniae Alr, and intend to 
incorporate the enzyme into the structural-based drug 
design program. Im et al. (2011) solved the structure of 
S. pneumoniae Alr and identified three regions on the 
enzyme that could be targeted for the structure-based 
drug design. Qiu et al. (2016) provided the first evi-
dence that D-alanine metabolism is essential for plank-
tonic growth and biofilm formation of Streptococcus 
mutans. It would be possible to take Alr of S. mutans as 
an antibacterial target to screen and optimize the safety 
and effective specificity of agents. Wei Y. et al. (2016) 
confirmed that alr is an essential factor in maintaining 
the growth and cell wall integrity of S. mutans. A series 
of in vivo and in vitro experiments demonstrated that 
Alr is essential for the cariogenicity of S. mutans. Alr 
might represent a promising drug target to control the 
prevalence of cariogenic S. mutans in a multi-species 
microbial consortium and be a potential target for the 
prevention and treatment of caries (Liu et al. 2018). 
Therefore, Alr is regarded as a drug target for further 
investigation in the course of development of effective 
drugs against S. iniae and a subject of mutational stud-
ies for the growth of mutants with enhanced activity 
that can be utilized for industrial purpose. D-alanine 
is also widely used for the production of infusion solu-
tions (Nachbauer et al. 1984), food additive (Awasthy 
et al. 2012), and in the manufacturing of artificial fibers 
(Teulé et al. 2009).
Purification and characterization of Alr from both 
Gram-positive and Gram-negative bacteria is an essen-
tial step towards an in-depth understanding of enzyme 
divers features, design new broad-spectrum antibio-
tics, and site-directed mutagenesis studies to improve 
the enzyme catalysis and stability. Hydroquinone and 
homogentisic acid are promising inhibitors of Alr that 
are capable of inhibiting the growth of both Gram-
positive and Gram-negative bacteria. Future investi-
gation will focus on finding the physiological role of 
Alr, exploring new novel antimicrobial agents against 
S. iniae and improving their efficacy by designing and 
analyzing their new derivatives that may have enhanced 
antimicrobial activity.
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